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Background: Obesity represents a growing global health issue. With revision total hip 
arthroplasty (THA) rates rising, the number of obese patients undergoing this 
procedure can be expected to increase. At present, there is limited evidence 
regarding complication rates for obese patients undergoing revision THA.  
Methods: A comparative cohort study was performed between patients with 
Ă ďŽĚǇŵĂƐƐ ŝŶĚĞǆ  ?D/ ?ш  ? ?ŬŐ ?ŵ2 and a separate group with a BMI < 30 kg/m2 
who underwent revision THA between 2005 and 2015. Patients undergoing revision 
for infection, periprosthetic fracture, recurrent dislocations and hip resurfacing 
failure were excluded. Primary outcome recorded was complications graded 2 or 
more by the Dindo classification. Secondary outcomes were radiographic assessment 
and revision. The null hypothesis was that there would be no difference between the 
two groups. 
Results: Sixty-ĨŝǀĞƉĂƚŝĞŶƚƐǁŝƚŚĂD/ш ? ?ŬŐ ?ŵ2 and 54 patients with a BMI 
of < 30 kg/m2 were identified. We found obese patients were 2.5 times more likely 
to suffer a complication than non-obese (38.4% cf 14.8%, p=0.02, 95% CI 1.11, 5.6). 
Obese patients were more likely to experience dislocation, leg length discrepancy, 
fracture, implant loosening, infection and pulmonary embolus. There was an 
association between ASA and complication rate (p=0.009). Age (p=0.454), pre-
operative diagnosis (p=0.588) and gender (p=0.651) were not predictive of a 
complication. The obese group had a significantly higher revision rate (12.3% cf 1.8%, 
p=0.039). 
Conclusion: This study utilises the largest cohort in the literature to 
demonstrate obese patients can expect higher complication and revision rates 
compared to the non-obese when undergoing revision THA. These patients should 




Obesity is becoming increasingly prevalent 1 and is associated with multiple other 
conditions including coronary artery disease and hypertension 2. Furthermore, 
osteoarthritis of the hip is common in these patients 3, many of who will 
subsequently undergo total hip arthroplasty (THA). Despite improved functional 
status post-operatively, obese patients generally do not lose weight 4,5. Although 
obese patients have greater forces acting across their hips due to increased weight, 
previous revision rates have been reported to be comparable with non-obese 
patients 6. This may be due to the associated lower activity levels. As the number of 
primary THA being performed increases, revision rates will also rise, with many of 
these procedures being performed in obese patients. Revision THA involves greater 
operative time, higher blood loss and a greater number of complications 7. Obesity 
has been associated with higher complication rates including periprosthetic joint 
infection 8 and respiratory compromise 9. The effects of obesity on outcomes of 
revision THA is uncertain given the paucity of evidence within the literature. The few 
studies existing have reported functional outcomes and satisfaction to improve 
significantly post-operatively, and often be either comparable or only slightly lower 
in obese patients compared to non-obese 6,10. However, variability in complication 
rates are not well understood with wide disparities reported. This may be a result of 
these studies having small patient cohorts 6,7,10 and variable body mass index (BMI) 
categorisations of obesity 7. This therefore limits our ability to adequately inform 
obese patients of appropriate complication rates. This study aimed to establish the 
complication rate in obese patients undergoing revision THA and determine if this 




Two cohorts were identified with a mean BMI difference of 9 kg/m2 over a 10 year 
period. The records of our prospectively collected arthroplasty database were 
reviewed to identify patients undergoing revision THA between 2005 and 2015. All 
procedures were performed at a single tertiary referral unit with follow-up at regular 
intervals for life.  Two hundred and eighteen patients were available for review. 
Patients undergoing revision for infection, periprosthetic fracture, recurrent 
dislocations and hip resurfacing failure were excluded to provide a more 
homogeneous group. This left 119 patients for analysis. A power calculation was 
performed which determined 114 patients were required to produce a power of 0.8. 
Our sample size was therefore sufficient to adequately power the study. All cases 
were revisions of primary THA. BMI as calculated by weight (kg) / height (m)2 was 
ĚŽĐƵŵĞŶƚĞĚĨŽƌĂůůƉĂƚŝĞŶƚƐ ?KďĞƐŝƚǇǁĂƐĚĞĨŝŶĞĚďǇĂD/ш ? ?ŬŐ ?ŵ2 11. An age, 
gender and American Society of Anesthesiologists (ASA) score matched comparator 
group was established consisting of patients with a BMI < 30 kg/m2  performed during 
the same time period and with the same pre-operative diagnoses as the obese 
group. All complications were recorded in our arthroplasty database by independent 
practitioners. Documentation in the database was rigorous and we therefore only 
presented complications graded 2 and above based on the classification by Dindo et 
al 12, which excludes any problems treated with antiemetics, antipyretics, analgesics, 
diuretics, electrolytes or physiotherapy. Radiographic analysis was performed on 




Survival analysis was done to determine the predictors of complications with age, 
gender, ASA score ĂŶĚD/ĂƐƉŽƐƐŝďůĞƉƌĞĚŝĐƚŽƌƐ ?&ŝƐŚĞƌ ?ƐĞǆĂĐƚƚĞƐƚǁĂƐƵƐĞĚƚŽ
test for an association between obesity and the need for a further revision 
operation. All analyses were done using SPSS (version 22). 
 Results 
 
^ŝǆƚǇĨŝǀĞƉĂƚŝĞŶƚƐǁŝƚŚĂD/ш  ? ?ŬŐ ?ŵ2 and 54 patients with a BMI of < 30 kg/m2 
were identified. Patient demographics of both groups are presented in table 1. 
Reasons for revision are presented in figure 1. Mean follow-up period was 3.6 years 
(range 1  ? 11.1) for the obese group and 2.8 (range 1  ? 11.1) for the non-obese. 
 
The obese group experienced 27 complications in 25 patients (38.4%). Eight patients 
(12.3%) underwent further revision surgery at a mean of 1.9 years post-operative. 
Reasons for further revision were recurrent dislocation (n=4), periprosthetic fracture 
(n=3) and infection (n=1). One patient who underwent a second revision for 
periprosthetic infection developed a deep infection requiring a Girdlestone 
procedure. Two patients (3.1%) died at 1.5 and 6.9 years post-operative for causes 
unrelated to their surgery.  
 
The non-obese group had eight complications in eight patients (14.8%). One patient 
(1.8%) underwent a further revision following a periprosthetic fracture. There were 
four deaths (7.4%) between 1.3 and 3.5 years post-operative for causes unrelated to 
surgery.  
 
Complications are listed in table 2. The obese group suffered higher rates of 
dislocation, leg length discrepancy, fracture, implant loosening, periprosthetic joint 
infection and pulmonary embolus. The difference in complication rate (p=0.02) and 
revision rate (p=0.039) was statistically significant. No difference in individual 
complication, e.g. dislocation, reached statistical significance due to small numbers. 
There was no association between obesity and death (p=0.208). There was evidence 
of an association between higher ASA scores and complication rate (p=0.009). Age 
(p=0.454), gender (p=0.651) and pre-operative diagnosis (p=0.588) were not 






Mean BMI (kg/m2) 34 (range 30  ? 44) 25 (range 16  ? 29) 
Mean age 67 70 
Male:female 1:1.2 1:1.1 




Figure 1: reason for revision in both groups. There was a comparable spread of pre-
operative diagnoses between the obese and non-obese group.  
  
Table 2 
Complication Obese (%) Non-obese (%) 
Dislocation 11 (16.9) 3 (5.5) 
Leg length discrepancy 2 (3.0) 0.0 
Implant loosening 3 (4.6) 2 (3.7) 
Periprosthetic fracture 4 (6.1) 1 (1.8) 
Intra-operative fracture 4 (6.1) 0.0 
Pulmonary embolus 2 (3.0) 0.0 
Periprosthetic joint infection 1 (1.5) 0.0 




Obesity represents a growing healthcare problem globally. Equally, the number of 
primary and revision hip arthroplasties being performed has been increasing over 
time 13. It is therefore crucial that we have a clear understanding of the impact of 
increased BMI on morbidity following joint replacement. This is particularly relevant 
given recent plans to delay offering hip and knee arthroplasty to patients with an 
increased on the National Health Service. Previous studies have reviewed the effect 
of increased BMI in primary THA 14,15, demonstrating a higher risk of early 
complications in the obese. At present, there is only limited and contradictory 
evidence relating to the role of obesity in revision arthroplasty. To our knowledge, 
this study represents the largest cohort of obese revision THA patients and 
demonstrates that this group have a significantly higher complication rate and are 
more likely to require a further revision when compared to non-obese individuals. 
 
Revision THA can successfully restore function and reduce pain in cases of failed 
primary hip arthroplasty. However, it has been shown to have greater operative 
time, blood loss 6 and key complications including dislocation 16 and infection. We 
report a dislocation rate of 16.9% in obese patients, compared to 5.5% in the non-
obese. This higher rate was also noted by Kim et al 6 who proposed this was related 
to extraarticular soft tissue impingement during hip adduction and flexion. The 
authors recommended large diameter femoral heads to reduce the risk of 
dislocation. Given the larger soft tissue dissection generally required in obese 
patients, Lübbeke et al 10 also proposed muscle weakness as a responsible factor for 
higher dislocation rates. In contrast to these studies, Perka and colleagues 7 found 
only an increase in operative time, with no difference in complication rates or 
mortality between obese and non-obese patients. This study included patients with 
a BMI of 25  ? 29.9 kg/m2 in the obese category, however, in contrast to the World 
,ĞĂůƚŚ KƌŐĂŶŝƐĂƚŝŽŶƐ ĚĞĨŝŶŝƚŝŽŶ ŽĨ ш  ? ? ŬŐ ?ŵ2 11 which may have influenced their 
results. 
 
Performing revision THA is more technically challenging than primary hip 
arthroplasty. Obesity can further increase the complexity of the procedure owing to 
difficulties with exposure, implant position and closure. Such difficulties may in turn 
be responsible for higher complications. In our study, we found higher rates of intra-
operative fracture, leg length discrepancy and periprosthetic joint infection, all of 
which may be related to technical challenges. Higher post-operative infection rates 
were also demonstrated by Houdek et al 17. This may result from associated 
comorbidities, prolonged operative time, greater trauma from exposure and relative 
immune deficiency. Weight loss has the potential to correct some of these factors 18 
and so represents an important factor in risk stratification. 
 
In the context of recurrent dislocation, infection and periprosthetic fracture, there is 
a clear case for early revision regardless of BMI. However, in the population we 
studied, consisting mainly of aseptic loosening, the timing of surgery may be less 
urgent. Given that this study has demonstrated a higher complication rate in obese 
patients, postponing surgery to facilitate weight loss may be justified. At the least, 
obese patients should be counselled that they are 2.5 times more likely to 
experience a complication than non-obese individuals.   
 
There are limitations to our study. Firstly, our sample size was not large. Our data 
was obtained from a tertiary referral centre over a 10 year period to maximise the 
number of available obese patients for inclusion however we were only able to 
obtain 65 patients. This may lead to other factors such as comorbidities influencing 
the results. However, this prospectively collected arthroplasty database provided a 
gender, age, ASA score and pre-operative diagnosis matched cohorts. The follow-up 
period was also relatively short which may have resulted in late complications not 
being identified for all patients. However, this factor was adjusted for in the 
statistical analysis and the majority of complications following hip arthroplasty tend 




Although revision THA can successfully manage a failed primary hip arthroplasty, 
obese patients who undergo this procedure can expect higher complication rates, 
particularly dislocation, and revision rates when compared to a non-obese cohort. 
Obese patients should be counselled on these risks pre-operatively and the potential 
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